| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 分部间抵销(元) | - | - | -6,957,845.55 | - | -13,438,068.83 |
| 复大医药经销业务(元) | - | 757,795,063.76 | - | - | 399,973,583.88 |
| 生化药业务(元) | 101,555,708.56 | 335,112,248.64 | 184,288,131.25 | 438,086,780.30 | 208,091,172.87 |
| 糖尿病药物业务(元) | - | 97,443,249.24 | 59,898,286.94 | 178,390,600.88 | 101,198,506.54 |
| 血液制品业务(元) | 789,912,921.83 | 1,451,686,875.96 | 762,179,426.29 | 1,314,866,123.63 | 696,445,494.32 |
| 药品经销(元) | - | - | 535,871,231.39 | 814,214,548.78 | - |
| 其他(元) | 3,690,144.29 | 9,942,069.06 | 4,969,585.75 | 13,143,261.51 | 9,556,357.87 |
| 营业成本(元) | |||||
| 分部间抵销(元) | - | - | - | - | -14,034,563.00 |
| 复大医药经销业务(元) | - | 673,488,931.56 | - | - | 347,183,785.29 |
| 生化药业务(元) | 27,349,042.00 | 79,025,365.47 | - | 90,864,633.57 | - |
| 糖尿病药物业务(元) | - | 34,148,735.33 | - | 49,134,801.95 | 25,910,888.46 |
| 血液制品业务(元) | 257,169,721.45 | 439,316,240.23 | - | 387,450,898.82 | - |
| 药品经销(元) | - | - | - | 709,782,012.46 | - |
| 其他(元) | 10,600,832.80 | 26,881,324.44 | - | 13,639,132.36 | - |
| 毛利(元) | |||||
| 分部间抵销(元) | - | - | - | - | 596,494.17 |
| 复大医药经销业务(元) | - | 84,306,132.20 | - | - | 52,789,798.59 |
| 生化药业务(元) | 74,206,666.56 | 256,086,883.17 | - | 347,222,146.73 | - |
| 糖尿病药物业务(元) | - | 63,294,513.91 | - | 129,255,798.93 | 75,287,618.08 |
| 血液制品业务(元) | 532,743,200.38 | 1,012,370,635.73 | - | 927,415,224.81 | - |
| 药品经销(元) | - | - | - | 104,432,536.32 | - |
| 其他(元) | -6,910,688.51 | -16,939,255.38 | - | -495,870.85 | - |
| 毛利率(%) | |||||
| 分部间抵销(%) | - | - | - | - | -4.44 |
| 复大医药经销业务(%) | - | 11.13 | - | - | 13.20 |
| 生化药业务(%) | 73.07 | 76.42 | - | 79.26 | - |
| 糖尿病药物业务(%) | - | 64.96 | - | 72.46 | 74.40 |
| 血液制品业务(%) | 67.44 | 69.74 | - | 70.53 | - |
| 药品经销(%) | - | - | - | 12.83 | - |
| 其他(%) | -187.27 | -170.38 | - | -3.77 | - |
| 收入构成(%) | |||||
| 分部间抵销(%) | - | - | -0.45 | - | -0.96 |
| 复大医药经销业务(%) | - | 28.57 | - | - | 28.53 |
| 生化药业务(%) | 11.34 | 12.64 | 11.96 | 15.88 | 14.84 |
| 糖尿病药物业务(%) | - | 3.67 | 3.89 | 6.47 | 7.22 |
| 血液制品业务(%) | 88.24 | 54.74 | 49.48 | 47.66 | 49.68 |
| 药品经销(%) | - | - | 34.79 | 29.51 | - |
| 其他(%) | 0.41 | 0.37 | 0.32 | 0.48 | 0.68 |
| 毛利构成(%) | |||||
| 分部间抵销(%) | - | - | - | - | 0.46 |
| 复大医药经销业务(%) | - | 6.03 | - | - | 41.03 |
| 生化药业务(%) | 12.37 | 18.30 | - | 23.03 | 0.00 |
| 糖尿病药物业务(%) | - | 4.52 | - | 8.57 | 58.51 |
| 血液制品业务(%) | 88.78 | 72.36 | - | 61.51 | 0.00 |
| 药品经销(%) | - | - | - | 6.93 | - |
| 其他(%) | -1.15 | -1.21 | - | -0.03 | 0.00 |